The Potential Value of Serum sCD14, PGLYRP2 and FGA Combined Indicators in the Diagnosis of Drug-Resistant Tuberculosis

The Potential Value of Serum sCD14, PGLYRP2 and FGA Combined Indicators in the Diagnosis of Drug-Resistant Tuberculosis

MAI Jinglan, FENG Xiong, YUN Fei, WU Kechang

PDF(1162 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(1162 KB)

Labeled Immunoassays and Clinical Medicine ›› 2022, Vol. 29 ›› Issue (2) : 296-300. DOI: 10.11748/bjmy.issn.1006-1703.2022.02.024

Clinical Investigation

The Potential Value of Serum sCD14, PGLYRP2 and FGA Combined Indicators in the Diagnosis of Drug-Resistant Tuberculosis

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 29(2): 296-300 https://doi.org/10.11748/bjmy.issn.1006-1703.2022.02.024

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1162 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉